Analysis of 7 cases of fallopian tube carcinosarcoma and literature review

黄建琴; 朱芝玲

doi:10.19401/j.cnki.1007-3639.2016.08.009

您当前的位置：

首页 >

文章列表页 >

Analysis of 7 cases of fallopian tube carcinosarcoma and literature review

更新时间：2025-12-31

- Analysis of 7 cases of fallopian tube carcinosarcoma and literature review
- China Oncology Vol. 26, Issue 8, Pages: 693-698(2016)
- 作者机构：
  
  复旦大学附属妇产科医院中西医结合科,上海,200090
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2016.08.009
  CLC：
- Published Online：19 October 2016，
  
  Published：19 October 2016
- 稿件说明：
移动端阅览
黄建琴,朱芝玲. 输卵管癌肉瘤7例分析并文献复习[J]. 中国癌症杂志, 2016, 26(8): 693-698.

黄建琴, 朱芝玲. Analysis of 7 cases of fallopian tube carcinosarcoma and literature review[J]. China Oncology, 2016, 26(8): 693-698.
黄建琴,朱芝玲. 输卵管癌肉瘤7例分析并文献复习[J]. 中国癌症杂志, 2016, 26(8): 693-698. DOI： 10.19401/j.cnki.1007-3639.2016.08.009.

黄建琴, 朱芝玲. Analysis of 7 cases of fallopian tube carcinosarcoma and literature review[J]. China Oncology, 2016, 26(8): 693-698. DOI： 10.19401/j.cnki.1007-3639.2016.08.009.

摘要

背景与目的：输卵管癌肉瘤是非常罕见的恶性肿瘤，易转移和复发，预后差。旨在回顾性分析输卵管癌肉瘤的临床表现、组织病理学、治疗和预后，并对既往相关文献进行复习。方法：回顾性分析7例输卵管癌肉瘤患者的临床表现、病理特点和治疗方式，随访生存时间，并复习相关文献。结果：7例输卵管癌肉瘤患者，最常见症状为阴道不规则流血(4/7，57.1%)。病理Ⅰa期1例，Ⅱa期1例，Ⅱb期1例，Ⅲb期l例，Ⅲc期3例。异源性4例(57.1%)，均见软骨成分，同源性3例(42.9%)。7例均行瘤体减灭术，6例接受化疗，无放疗病例。存活5例，死亡2例。生存时间超过5年的有3例，最长的至末次随访已存活9年零6个月。结论：病理检查为输卵管癌肉瘤的确诊手段。病理同源性间质成分预后优于异源性间质成分。满意的瘤体减灭术，术后给予足够疗程的TP方案化疗，且全身静脉化疗联合局部腹腔灌注化疗可能是治疗输卵管癌肉瘤的有效治疗方法。

Abstract

Background and purpose: Fallopian tube carcinosarcoma is a rare malignant tumor that is prone to metastasis and recurrence. Patients with the malignancy often have poor prognosis. This paper retrospectively analyzed the clinical manifestation

pathology

treatment and prognosis of fallopian tube carcinosarcoma. Methods: The clinical manifestations

pathological features

treatment and survival time of 7 cases of fallopian tube carcinosarcoma were retrospectively analyzed. Results: The most common symptoms of 7 cases of fallopian tube carcinosarcoma were irregular vaginal bleeding (4/7

57.1%). Among 7 cases

one case was stage Ⅰa

1 stage Ⅱa

1 stage Ⅱb

1 stage Ⅲb

and 3 stage Ⅲc. Four cases (57.1%) were heterologous and found to have cartilage components whereas 3 cases (42.9%) were homologous. Seven cases were performed with tumor volume reduction surgery

and 6 cases with chemotherapy

while no one received radiotherapy. Five patients survived and 2 were dead. The survival time of 3 patients was more than 5 years. The longest survival time to the end of the follow-up was 114 months. Conclusion: The pathological examination is the diagnostic means of fallopian tube carcinosarcoma. The prognosis of the patients with the pathological characteristics of the homologous is better than that of the heterologous. Satisfactory reduction of tumor

postoperative chemotherapy with adequate TP regimen

combined with systemic chemotherapy and intraperitoneal chemotherapy may be an effective treatment for fallopian tube carcinosarcoma.

关键词

Keywords

references

Views

2960

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)

Expert consensus on diagnosis and treatment of hematologic malignancies with solid tumors (2025 version)

MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma

Research progress on treatment of pleural effusion related to immune checkpoint inhibitors

Related Author

The Society of Breast Cancer China Anti-Cancer Association

Breast Oncology Group of the Oncology Branch of the Chinese Medical Association

Multiple Primary and Unknown Primary Tumors Special Committee of China Anti-Cancer Association

Shanghai Anti Cancer Association Multiple Primary and Unknown Primary Tumor Special Committee

Lymphocytic Disease Group, Hematology Branch, Chinese Medical Association

Rare Disease Group, Hematology Branch, Chinese Medical Association

Tong WANG

Wei SUN

Related Institution

Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Fudan University, Institute of Thoracic Oncology, Fudan University, Department of Oncology, Shanghai Medical College, Fudan University

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Radiation Oncology, Shanghai Clinical Research Center for Radiation Oncology, Department of Oncology, Shanghai Medical College, Fudan University

Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

Department of Oncology, The First Affiliated Hospital of Zhengzhou University

AI问答

⁰